Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-05-14
2011-10-25
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S343000, C514S427000, C546S187000, C546S268100, C548S531000, C548S537000
Reexamination Certificate
active
08044072
ABSTRACT:
The invention relates to compounds having the formula (I):Wherein R1, R2, R3, R4, R5, R6, R7and R8and A-R9are as defined herein. Also disclosed are the preparative methods for the compounds of formula (I) and their use in therapy.
REFERENCES:
patent: WO 03/007887 (2003-01-01), None
patent: WO 2006/024777 (2006-03-01), None
Bouaboula, M., et. al., A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-Activated Protein Kinase Activation Stimulated by Insulin or Insulin-Like Growth Factor 1, The Journal of Biological Chemistry, vol. 272, No. 35, (1997), pp. 22330-22339.
Bouaboula, et. al., Stimulation of Cannabinoid Receptor CB1 Induces Krox-24 Expression in Human Astrocytoma Cells, The Journal of Biological Chemistry, vol. 270, No. 23, (1995), pp. 13973-13980.
Knight, D. W., et. al., An Approach to 2,3-Dihydropyrroles and B-Iodopyrroles Based on 5-Endo-Dig Cyclisations, J. Chem. Soc., Perkin Trans., vol. 1, pp. 622-628, (2002).
Rinaldi-Carmona, M., et. al., Biochemical and Pharmacological Characterisation of SR141716A, The First Potent and Selective Brain Cannabinoid Receptor Antagonist, Life Sciences, vol. 56, No. 23/24, pp. 1941-1947, (1995).
Rinaldi-Carmona, M., et. al., Characterization of Two Cloned Human CB1 Cannabinoid Receptor Isoforms, The Journal of Pharmacology and Experimental Therapeutics, vol. 278, No. 2, pp. 871-878, (1996).
Rinaldi-Carmona, M., et. al., SR141716A, A Potent and Selective Antogonist of the Brain Cannabinoid Receptor, Febs Letters, vol. 350, (1994) pp. 240-244.
Rinaldi-Carmona, M., et. al., SR147778 [5-(4-Bromophenyl)-1-(2,4-Dichlorophenyl)-4-ethyl-N-(1-Piperidinyl)-1H-Pyrazole-3-Carboxamide], A New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization, The Journal of Pharmacology and Experimental Therapeutics, vol. 310, No. 3, (2004), pp. 905-914.
Westeringh, C., et. al., 4-Substituted Piperidines. I. Derivatives of 4-T-Amino-4-Piperidinecarboxamides, Journal of Medicinal Chemistry, (1964), vol. 7, No. 5, 619-623.
Barth Francis
Congy Christian
Hortala Laurent
Rinaldi-Carmona Murielle
Anderson Rebecca
Sanofi - Aventis
Scully , Scott, Murphy & Presser, P.C.
Shterengarts Samantha
LandOfFree
Pyrrole derivatives, preparation thereof and therapeutic use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrole derivatives, preparation thereof and therapeutic use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole derivatives, preparation thereof and therapeutic use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4264592